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sies from 15 patients on anti-PD-1 agents and 9 biopsies
from 7 patients on anti-PD-1 plus ipilimumab therapy. Clini-
cally, all except two patients presented with discrete, viola-
ceous exanthematous papules to plaques. The lichenoid
inflammation in the majority (18 of 29 biopsies) was florid
although the rest of histology was quite heterogeneous. Nev-
ertheless, there was frequent involvement of the superficial
follicular epithelium and acrosyringium, as well as a
propensity to blister which occurred in about 20% of the
biopsies. Occasional patients had disease closely resembling
lichen planus, although all of these biopsies had some atypi-
cal features for lichen planus such as parakeratosis. Dermal
eosinophils were common particularly in those with mild
inflammation. The lichenoid reactions were responsive to
topical steroid or oral systemic treatment in general and the
anti-PD-1 agent had to be ceased in only one patient.
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Introduction: It is unclear if the poor prognosis of patients
with scalp melanoma compared to other cutaneous head
and neck melanoma (CHNM) is due to an inherent risk
associated with scalp location. This study aims to describe
patient survival for scalp melanoma compared to other
CHNM, and determine if any differences can be explained
by patient or tumour characteristics.
Methods: A retrospective cohort study was performed of
all invasive primary CHNM patients seen at the Victorian
Melanoma Service over a 20 year period. For each case,
survival status up to September 2014 was obtained from
the Victorian Cancer Registry. Comparisons of melanoma-
specific survival (MSS) were made between scalp and
other CHNM. Multivariable Cox proportional hazards
regression was performed to determine associations with
survival.
Results: On univariate analysis, patients with scalp mela-
noma had worse MSS than other CHNM (hazard ratio,
HR = 2.22, 95% CI 1.59–3.11). This association was largely
explained by Breslow thickness of scalp melanoma (HR
adjusted for thickness = 1.26, 95% CI 0.89–1.79), and fur-
ther by age and sex (HR adjusted for thickness, age and
sex = 1.13, 95% CI 0.79–1.61). Although scalp location was
not associated with MSS on multivariable analysis for
CHNM overall, scalp location had a strong association with
MSS for CHNM between 0.76–1.5 mm thick (HR = 5.5, 95%
CI 1.5–19.6).
Conclusion: Scalp melanoma has poorer survival than
other CHNM, but this can be explained by patient age, sex
and tumour histological characteristics. Further research
is required to validate our findings for 0.76–1.5 mm
CHNM.
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Background: Isotretinoin is the most efficacious treatment
for acne vulgaris. It has been controversially associated
with depression, suicidal ideation and suicide1. Current lit-
erature on this issue remains conflicted and lacks well
designed blinded randomized controlled trials2.
Aim: To assess Australian Dermatologists’ experiences
and perceptions with acne vulgaris patients treated with
Isotretinoin and the development of depression, suicidal
ideation and suicide. To conduct a feasibility study for a
triple blind randomized controlled trial investigating the
effects of Isotretinoin on depression and quality of life.
Methods: This project consisted of two complimentary
original studies. A questionnaire was conducted at the 48th
Australasian Dermatologists’ Annual Scientific Meeting.
The feasibility study randomized all acne vulgaris patients
meeting inclusion criteria who were willing to participate
to Isotretinoin or Doxycycline for 2 weeks. Questionnaires
screening for depression and quality of life were com-
pleted at baseline and at 2 weeks.
Results: The questionnaire surveyed 120 Dermatologists
with 73 responses included. Many Dermatologists had
observed acne vulgaris patients on Isotretinoin develop
depressive symptoms (77%). Most (66%) believe Isotretinoin
could cause depression. The feasibility study screened 200
acne vulgaris patients and found despite the superior effi-
cacy of Isotretinoin, patients would accept randomization.
Conclusion: Many Australian Dermatologists are seeing
acne vulgaris patients treated with Isotretinoin develop
depressive symptoms and believe Isotretinoin is the cause.
There is a distinct difference between clinical opinion and
that in the literature. The feasibility study demonstrates a
triple blind randomized controlled trial investigating the
effects of Isotretinoin on depression and quality of life is
possible.
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Although documented as a clinical entity by Bazin in 1851,
and well represented in older literature, Acne Necrotica
now rates only brief mention in major text book of derma-
tology or dermatopathology with a paucity of journal refer-
ences in recent years. This presentation seeks to
demonstrate that this condition is prevalent, a significant
source of chronic patient morbidity, but significantly
unrecognised due to challenging barriers to both clinical
and histopathologic diagnosis. We address these diagnostic
impediments, discuss management options and further
reflect on the etio-pathology of this confounding condition.
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Background: Acne Vulgaris is one of the most common
dermatological presentations in General practice. Acne
scarring is a known major consequence of late referrals for
Isotretinoin treatment as the drug is effective in preventing
scarring if started early. This project will investigate the bar-
riers and facilitators of referral to dermatologists from GPs
for Isotretinoin treatment in regional and rural areas.
Methods: Twenty semi-structured telephone interviews
were conducted with GPs from Metropolitan, Regional, and
Rural area in the Illawarra Shoalhaven region. The inter-
views were audio-taped and transcribed verbatim. Inter-
views were then analyzed by three independent researchers
using a constant comparative analysis framework.
Results: Three core themes of participants’ responses were
identified.
Theme 1: The GP approach to acne presentation. As part
of this theme it became apparent that some participants
had a comprehensive holistic approach to acne patients,
whereas others had more of unidimensional approach.
Theme 2: Patient factors contributed to acne treatment
approaches. These factors included recognizing scarring
as a major complication of acne, recognizing patient psy-
chological distress, and prior treatment received.
Theme 3: GP participants believed that shared goals with
their dermatologist colleagues were very important. They
also believed that ready access to dermatologists would
help to better manage the condition and prevent complica-
tions, mainly acne scarring and its long term psychological
effect on patients.
Conclusions: The study found that there were some limita-
tions in the way which GPs were managing acne treatment
in community settings. Based on study findings it could be
suggested that a number of strategies could be incorporated
to help address these limitations. These strategies could
include professional development education regarding
acne presentations, early recognition of acne scarring, a
more collaborative relationship between GPs and specialist
dermatologists, a dermatological telehealth consultation
especially in regional and rural environment.
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Antinuclear antibody (ANA) remains the best screening
test, while DS-DNA has prognostic value for the risk of
renal disease. Anti-Histone antibodies are associated with
Drug-induced LE. SSA/SSB are associated with Sjogren’s
syndrome, Neonatal LE and SLE. Sm is associated with
SLE, RNP with Mixed CTD, anti-Centromere with CREST
Syndrome, Scl70 with Systemic sclerosis, and tRNA syn-
thetases (e.g., Jo-1) with dermatomyositis.
Antineutrophil cytoplasmic (ANCA) testing can be helpful
in a number of disease states. Proteinase 3 (PR3)/c (cyto-
plasmic) ANCA is positive in 80–90% of patients with gran-
ulomatosis with angiitis (Wegener’s granulomatosis).
Myeloperoxidase (MPO): p (perinuclear) ANCA is present
in 70–90% of patients with Churg-Strauss Syndrome and
80–90% of patients with Microscopic polyangiitis. Diagnos-
tic Criteria for granulomatosis with angiitis (Wegener’s
granulomatosis) (2/4 required) include nasal or oral
inflammation, development of painful or painless oral
ulcers or purulent or bloody nasal discharge, abnormal
chest radiograph showing the presence of nodules, fixed
infiltrates, or cavities, microhematuria (>5 red blood cells
per high power field) or red cell casts in urine sediment,
and granulomatous inflammation on biopsy.
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